NeuRA launches world’s largest clinical trial for phantom limb pain
Researchers at NeuRA’s Centre for Pain Impact are carrying out world’s largest clinical trial for two potential treatments for phantom limb pain.
Phantom limb pain is a distressing and disabling condition that has baffled scientists and clinicians and affects up to 80% of people who have had a limb amputated or had a spinal cord injury.
Read more: NeuRA launches world’s largest clinical trial for phantom…
Latest News & Events
Professor Matthew Kiernan AM awarded the 2024 GSK Award for Research Excellence
September 2, 2024Professor Matthew Kiernan AM, CEO and Institute Director at NeuRA and Scientia Professor of Neuroscience at UNSW, has won the prestigious 2024 GSK Award for Research Excellence for his work in neurodegenerative diseases.
Lived experience is the beating heart of mental health and suicide prevention
September 2, 2024Mental ill health and suicidal distress are deeply human experiences – which is why keeping people safe during these challenging times requires a human touch.
Stroke associated with long-term cognitive decline
September 2, 2024New evidence from the Centre for Healthy Brain Ageing (CHeBA) indicates that older adults who experience a stroke for the first time will have substantial immediate and accelerated long-term cognitive decline.
Mindgardens Neuroscience Network acknowledges the Traditional Owners of Country throughout Australia and recognises their continuing connection to land, waters and community. We pay our respect to them and their cultures, and to Elders past, present and emerging.
We acknowledge the voices of people with lived experience, their carers, families and kinship groups. We recognise the expertise acquired through living with a mental health, drug and alcohol or neurological disorder and acknowledge those who care for people on their recovery journey. We place lived experience at the heart of all that we do.
Brings together the strengths of four founding organisations
